CAROL G. SIMON CANCER CENTER AT MORRISTOWN MEMORIAL HOSPITAL
| Site name: | Carol G. Simon Cancer Center at Morristown Memorial Hospital | Active Prostate Cancer Clinical Trials: | |
| Contact: | Contact Person | That match your search: | No search performed |
| Phone: | 973-971-6100 | ||
| Site email: | Not Provided |
5
Active Prostate Cancer Clinical Trials at Carol G. Simon Cancer Center at Morristown Memorial Hospital:
| TRIAL ID | TITLE | TRIAL PHASE |
|---|---|---|
| NCT00786682 | A Phase II Study of Docetaxel and Modulation of Autophagy With Hydroxychloroquine for Metastatic Hormone Refractory Prostate Cancer | Phase 2 |
| NCT00430183 | Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer | Phase 3 |
| NCT00726596 | NJ 1808: Autophagic Cell Death in Patients With Hormone-Dependent Prostate-Specific Antigen Progression After Local Therapy for Prostate Cancer | Phase 2 |
| NCT00309985 | CHAARTED: ChemoHormonal Therapy Versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer [CHAARTED] | Phase 3 |
| NCT00079001 | A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men With Prostate Cancer Metastatic to Bone | Phase 3 |